ALS
INDUSTRY
ANALYSIS
GROUP MEMBERS:
MANVI
KARTHIKEYA
VAMSI
VINOD
INDUSTRY ANALYSIS
The Indian Pharmaceutical industry today is in the front rank of India’s science based industries with wide range capabilities in the complex field of drugs and technology.
MARKET SIZE
It ranks 4th in the world pertaining to the
Volume of sales.
Estimated worth of Indian
Pharmaceuticals Industry is US$ 6 billion
Almost 70% of domestic demand for bulk drugs is catered by Indian Pharma
Industry
Growth rate of the industry is 13% per year GROWTH SHARE
TECHNOLOGICAL
CHANGE
With the help of change in technology of 3g and 4g these pharmaceuticals industry find new ways to engage patients with useful service to improve their quality of life
In healthcare they are seeing for EMR with genomic and genetic dataand financial data
“They can improve and focus on the health and wellbeing of the patients they serve, by engaging with customers and providing better customer service
MAJOR PLAYERS
INDUSTRY
COMPETITION
Most
competitive industries in the company with as many as 10000 as players. Top player in the country has only 6% market share and top have only 18%
High growth prospects
Very low entry barriers
Fixed cost requirement is low and need for working capital is high
BARGAINING POWER OF
BUYERS
End
user of the product is different from the influencer
Consumer has no choice but to buy what doctor says
Buyers are scattered and they as such does not wield much power in the pricing of the products
BARGAINING POWER OF
SUPPLIERS
Pharma
industry depends upon several organic chemicals
Very competitive and fragmented industry Chemicals are largely a commodity
Suppliers have very low bargaining power Pharma industry can switch from their suppliers without incurring a very high cost BARRIERS TO ENTRY
Most
easily accessible industries for an enterpreneur in india
Capital requirement for the industry is very low
Point of